Stock APLLTD ALEMBIC PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Alembic Pharmaceuticals Limited

Equities

APLLTD

INE901L01018

Delayed NSE India S.E.
Other stock markets
 03:32:25 13/06/2024 pm IST 		5-day change 1st Jan Change
883 INR -0.93% Intraday chart for Alembic Pharmaceuticals Limited -1.15% +16.27%
07/06 Alembic Pharmaceuticals Limited Announces Superannuation of Chandrahas Shetty as President-Human Resources (India Branded Business) CI
30/05 Alembic Pharmaceuticals Gets US FDA Final Nod for Sacubitril and Valsartan Tablets MT

Evolution of the average Target Price on Alembic Pharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

c3d0f70cf428d31a5e08.81EXcqmWm9uWm7It3M4AaPCg-A5oy949ey8Saqrok84.qShAGv3f-LHB9MZdsqFvKcbvzGcFs416VnpTLZ-C9IWCCUUGhLvJiPTx3Q~20c553f9061a2be6697bd2561b912e81

Analyst Recommendations on Alembic Pharmaceuticals Limited

India's Alembic Pharma beats estimates on higher domestic sales RE
Alembic Pharmaceuticals Limited Approves the Issue of Unsecured Listed Rated Redeemable Non-Convertible Debentures CI
Alembic Pharmaceuticals Limited Announces Unaudited Consolidated and Standalone Financial Results for the First Quarter Ended June 30, 2018; Provides Tax Rate Guidance for the Fiscal Year 2019 CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
891.2 INR
Average target price
980.3 INR
Spread / Average Target
+9.99%
High Price Target
1,229 INR
Spread / Highest target
+37.90%
Low Price Target
845 INR
Spread / Lowest Target
-5.19%

Consensus detail

Consensus revision (last 18 months)

Ratings for Alembic Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. APLLTD Stock
  4. Consensus Alembic Pharmaceuticals Limited